Veeva SystemsVEEV +0.22%83 ROC (Joel Greenblatt) % is 724.84% as of Apr. 2026, which is 76% above its 10-year median of 412.94. GuruFocus rates VEEV with a GF Score™ of 83/100 and a GF Value™ of $288.16 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 669 Healthcare Providers & Services companies, Veeva Systems ranks better than 98.8% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Veeva Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 724.84%.
The historical rank and industry rank for Veeva Systems's ROC (Joel Greenblatt) % or its related term are showing as below:
VEEV'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 247.88 Med: 412.94 Max: 689.88
Current: 686.25
During the past 13 years, Veeva Systems's highest ROC (Joel Greenblatt) % was 689.88%. The lowest was 247.88%. And the median was 412.94%.
VEEV's ROC (Joel Greenblatt) % is ranked better than 98.8% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs VEEV: 686.25
Veeva Systems's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 12.50% per year.
Veeva Systems (NYSE:VEEV) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Veeva Systems ROC (Joel Greenblatt) % Related Terms
Veeva Systems ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Veeva Systems's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VEEV vs BTSG, TEM, HQY: ROC (Joel Greenblatt) % Comparison
For the Health Information Services subindustry, Veeva Systems's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Veeva Systems's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 724.84% mean?
Veeva Systems (VEEV) has a ROC (Joel Greenblatt) % of 724.84% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Veeva Systems and its competitors. This is 76% above median its historical median of 412.94. Over the past decade, Veeva Systems' ROC (Joel Greenblatt) % has ranged from 247.88 to 689.88. According to the industry distribution chart, Veeva Systems ranks #8 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 1.2%.
Is Veeva Systems' ROC (Joel Greenblatt) % too high?
Veeva Systems' current ROC (Joel Greenblatt) % of 724.84% is 76% above median its 10-year median of 412.94. Over the past 10 years, this metric has ranged from a low of 247.88 to a high of 689.88. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Veeva Systems' value of 724.84% is 5717.3% above this industry median. Based on the distribution chart, Veeva Systems ranks #8 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' ROC (Joel Greenblatt) % compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #8 out of 669 companies for ROC (Joel Greenblatt) %. This places Veeva Systems in the top 1% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.46. Veeva Systems' value of 724.84% is 5717.3% above this benchmark. Historically, Veeva Systems' own ROC (Joel Greenblatt) % has ranged from 247.88 to 689.88 over the past decade. While the company's 10-year median is 412.94 vs. the industry median of 12.46, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current ROC (Joel Greenblatt) % of 724.84% is 5717.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current ROC (Joel Greenblatt) % is 724.84%, which is 76% above median its own 10-year median of 412.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $288.16, compared to a current price of $190.12 — trading 34% below its estimated fair value. The current ROC (Joel Greenblatt) % is 724.84%, which is 76% above median its 10-year median of 412.94 and 5717.3% above the Healthcare Providers & Services industry median of 12.46. Veeva Systems' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Veeva Systems (VEEV), the current ROC (Joel Greenblatt) % is 724.84% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $190.12 is trading 34% below its estimated GF Value™ of $288.16.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
ROC (Joel Greenblatt) %: 724.84% (76% above median its 10-year median of 412.94)
GF Value™: $288.16 vs. price of $190.12 (34% below fair value)
Industry Position: 5717.3% above the Healthcare Providers & Services median (#8 of 669)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
83GF Score
Get the complete analysis for VEEV
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
